Ramesh Kaul

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Alectos Therapeutics Inc., Merck Sharp + Dohme Corp., Zalicus Pharmaceuticals, Ltd.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramesh Kaul. Retrieved from https://idiyas.com/inventor/ramesh-kaul

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 58.3

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 7.4

ph-index = 5

Forward Citations = 78(Granted Patents)

Location History:

Burnby, CA (2017)
Burnaby, CA (2012 - 2018)

Company Filing History:

8 out of 19

Alectos Therapeutics Inc.

patents

5 out of 2,405

Merck Sharp + Dohme Corp.

patents

4 out of 8

Zalicus Pharmaceuticals, Ltd.

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528773 - NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF (2026-01-20),

2. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),

3. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),

4. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),

5. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),

6. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),

7. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),

8. 9243020 - Selective glycosidase inhibitors and uses thereof (2016-01-26),

9. 9096522 - N-piperidinyl acetamide derivatives as calcium channel blockers (2015-08-04),

10. 8569344 - N-piperidinyl acetamide derivatives as calcium channel blockers (2013-10-29),

11. 8377968 - N-piperidinyl acetamide derivatives as calcium channel blockers (2013-02-19),

12. 8133998 - Bicyclic pyrimidine derivatives as calcium channel blockers (2012-03-13),

Title: Ramesh Kaul: Pioneering Inventor from Burnaby

Introduction: Ramesh Kaul is a distinguished inventor hailing from Burnaby, Canada, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Ramesh Kaul's recent patents include advancements in renewable energy technologies, sustainable packaging solutions, and artificial intelligence applications.

Career Highlights: With a career spanning over two decades, Ramesh Kaul has worked with leading research institutions and multinational companies, consistently pushing the boundaries of technological innovation.

Collaborations: Throughout his career, Ramesh Kaul has collaborated with top universities, innovative startups, and established corporations to bring his inventive ideas to life, fostering a culture of creativity and progress.

Conclusion: Ramesh Kaul's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs in Burnaby and beyond.

Profile summary based on public USPTO records.